Ossifying Fibromyxoid Tumor of Soft Parts
- 1 November 2011
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 35 (11) , 1615-1625
Abstract
Ossifying fibromyxoid tumor (OFMTs) of soft parts is a rare soft tissue and bone tumor of borderline malignancy displaying an uncertain line of differentiation. The existence of fully malignant OFMT is controversial. To better understand the natural history and line of differentiation taken by OFMT, we studied 46 cases by light microscopic, immunohistochemical (IHC), genomic, proteomic, and fluorescence in situ hybridization (FISH) methods. Cases were classified according to the 2003 Folpe and Weiss system. Clinical and follow-up information was obtained. IHC for S-100 protein, desmin, epithelial membrane antigen (EMA), cytokeratins, smooth muscle actin (SMA), INI-1, neurofilament protein (NFP), CD56d excitatory amino acid transporter-4 (EAAT4), and MUC4 was performed on formalin-fixed, paraffin-embedded (FFPE) tissues. Gene expression profiling and proteomic studies were conducted on FFPE tissues from 13 and 5 cases, respectively. FISH for INI-1 was performed on 10 cases. The 46 tumors arose in 29 men and 17 women (median age, 52 y; range 39 to 63 y) and involved the proximal (N=17) and distal extremities (N=13), head and neck (N=9), and trunk (N=5). Median tumor size was 5.4 cm (range, 1.0 to 21.0 cm). Cases were classified as typical OFMT (26 of 46, 57%), atypical OFMT (5 of 46, 11%), and malignant OFMT (15 of 46 cases, 32%). Clinical follow-up (27 cases, median 55 months’ duration) showed all patients with typical and atypical OFMT to be alive without disease. Adverse events, including 3 local recurrences, 3 metastases, and 3 deaths, were seen only in malignant OFMT. IHC results were as follows: S-100 protein (30 of 41, 73%), desmin (15 of 39, 38%), cytokeratin (4 of 35, 11%), EMA (5 of 32, 16%), SMA (2 of 34, 6%), INI-1 (lost in mosaic pattern in 14 of 19, 74%), EAAT4 (31 of 39, 80%), MUC4 (3 of 14, 21%), NFP (8 of 10, 80%) and CD56 (6 of 14, 43%). Gene expression profiling showed typical and malignant OFMTs to cluster together, distinct from schwannian tumors. Proteomic study showed expression of various collagens, S-100 protein, and neuron-related proteins. FISH showed INI-1 deletion in 5 of 7 (71%) cases. We conclude that malignant OFMTs exist and may be recognized by the previously proposed criteria of Folpe and Weiss. Expression of neuron-related markers, in addition to Schwann cell and cartilage-associated markers, suggests a “scrambled” phenotype in OFMTs. Loss of INI-1 or other genes on 22q is likely important in the pathogenesis of these rare tumors.Keywords
This publication has 38 references indexed in Scilit:
- MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid SarcomaAmerican Journal of Surgical Pathology, 2011
- Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysisLaboratory Investigation, 2011
- Reduced expression of SMARCB1/INI1 protein in synovial sarcomaLaboratory Investigation, 2010
- Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissuesLaboratory Investigation, 2008
- Immunohistochemical Analysis Supports a Role for INI1/SMARCB1 in Hereditary Forms of Schwannomas, but Not in Solitary, Sporadic SchwannomasBrain Pathology, 2008
- Ossifying Fibromyxoid Tumor: Invariable Ultrastructural Features and Diverse Immunophenotypic ExpressionUltrastructural Pathology, 2007
- Ossifying Fibromyxoid Tumor: Modified Myoepithelial Cell Tumor? Report of Three Cases with Immunohistochemical and Electron Microscopic StudiesUltrastructural Pathology, 2005
- Ossifying fibromyxoid tumor of soft parts.Cancer Genetics and Cytogenetics, 2002
- Atypical and Malignant Variants of Ossifying Fibromyxoid TumorAmerican Journal of Surgical Pathology, 1995
- Ossifying Fibromyxoid Tumor of Soft PartsActa Pathologica Japonica, 1991